Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Utah Sues GlaxoSmithKline Over Avandia Fraud
Pharmalot
Friday, November 12, 2010 - 9:15am
tags:
Avandia, fraud, utah, GSK, lawsuits
Human Genome: FDA Reviews Lupus Drug
TheStreet.com
Friday, November 12, 2010 - 9:07am
tags:
FDA, lupus, Human Genome Sciences, GSK, Benlysta, advisory panels
J&J Will Unveil New Drug Results
WSJ Online
Thursday, November 11, 2010 - 10:35pm
tags:
JNJ, statins, rivaroxaban
Endo Pharma Beats, Guides Up
Yahoo/Zacks.com
Thursday, November 11, 2010 - 10:17pm
tags:
earnings, Endo
Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Bloomberg
Thursday, November 11, 2010 - 6:39pm
tags:
lupus, Human Genome Sciences, M&A, Benlysta
Cardiome Pharma 3Q profit surges on Merck payment
Yahoo/AP
Thursday, November 11, 2010 - 5:48pm
tags:
earnings, Merck, Cardiome
Dendreon trades higher on prostate drug review
Yahoo/AP
Thursday, November 11, 2010 - 5:47pm
tags:
Dendreon, Provenge, vaccines, prostate cancer
Biotech IPOs struggling as one is pulled and another falls short
Fierce Biotech
Thursday, November 11, 2010 - 5:38pm
tags:
IPOs, biotech, Ikaria
Loss at Enzon Wider than Expected
Yahoo/Zacks.com
Thursday, November 11, 2010 - 5:36pm
tags:
earnings, Enzon
Is Johnson & Johnson Earning its Keep?
Motley Fool
Thursday, November 11, 2010 - 5:35pm
tags:
JNJ, Eli Lilly, Perrigo Company, Allergan
AstraZeneca not done with cost cuts
Reuters
Thursday, November 11, 2010 - 12:03pm
tags:
AstraZeneca, David Brennan, Pharma CEOs
Valeant Posts Loss
Yahoo/Zacks.com
Thursday, November 11, 2010 - 11:59am
tags:
earnings, Valeant Pharmaceuticals
Bone Drug Suits Raise Questions for Doctors, and Juries
NY Times, NY
Thursday, November 11, 2010 - 11:01am
tags:
osteoporosis, Merck, lawsuits, Fosamax
Ranbaxy Third-Quarter Profit More Than Doubles on Generic Herpes Treatment
Bloomberg
Thursday, November 11, 2010 - 11:00am
tags:
Ranbaxy, earnings
How a Sleeping Pill Company Increased Prices 300% Without Anyone Noticing
BNET Pharma
Thursday, November 11, 2010 - 10:58am
tags:
drug pricing, insomnia, Xyrem, Jazz Pharmaceuticals
Johnson & Johnson Tries To Resolve Risperdal Probe
Pharmalot
Thursday, November 11, 2010 - 10:57am
tags:
JNJ, Risperdal, antipsychotics
Centocor asks FDA to expand use of Simponi
Yahoo/AP
Thursday, November 11, 2010 - 10:55am
tags:
Janssen Biotech, FDA, arthritis, Simponi, JNJ
German Drug Reform Seen Boosting Innovation, Handelsblatt Says
Bloomberg
Thursday, November 11, 2010 - 10:54am
tags:
Germany, Europe, innovation, drug pricing
Novartis Halts Cancer Drug Trial
TheStreet.com
Thursday, November 11, 2010 - 9:17am
tags:
Novartis, lung cancer, ASA404
Few Teenage Girls, Young Women Get HPV Vaccines
Pharmalot
Thursday, November 11, 2010 - 9:02am
tags:
HPV, vaccines, Cervarix, Gardasil, Merck, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.